AlphaStocks
3.2
Weak

Doximity, Inc. (DOCS)

Health Care / Health Care Technology

S&P MidCap 400

$21.84

Scores poorly across most models. Proceed with caution.

Weak

Score based on 4 of 5 models — moderate confidence

#989out of 1121 in Health Care

Is Doximity, Inc. a Good Investment in 2026?

Doximity, Inc. (DOCS) scores 3.2 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Lynch model rates Doximity, Inc. as Strong (PEG 0.9 · Fast Grower). However, the Graham model rates it Caution — Significantly above fair value. Doximity, Inc. currently trades below its estimated fair value of $28, suggesting potential upside. Doximity, Inc. ranks #989 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E22.2ROE19.8Market Cap4B

Estimated Fair Value

$27.8722% below

Fair value above market price. P/E of 22x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Strong

PEG 0.9 · Fast Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Doximity, Inc. (DOCS) a good investment?
Based on AlphaStocks' composite analysis, Doximity, Inc. (DOCS) scores 3.2 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. P/E of 22x is moderate for this quality level.
What is Doximity, Inc.'s Piotroski F-Score?
Doximity, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is DOCS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $28, DOCS appears undervalued. The stock currently trades 22% below its estimated fair value. Fair value above market price. P/E of 22x is moderate for this quality level.
How does DOCS compare to other Health Care stocks?
Doximity, Inc. ranks #989 out of 1121 stocks in the Health Care sector, placing it in the top 88% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about DOCS?
AlphaStocks evaluates DOCS using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Strong. These models are combined into a single composite score of 3.2/10.

Similar Stocks

PARRBFAMAZN

Compare DOCS with

DOCS vs PARRDOCS vs BFAMDOCS vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer